Table 3 Clinical and Laboratory investigation results in participants
Baseline parameters | All Subjects | Male | Female | p |
|---|---|---|---|---|
|  | mean ± SD | mean ± SD | mean ± SD |  |
SBP(mmHg) | 140.8 ± 26.9 | 138.6 ± 26.8 | 142.7 ± 27.2 | 0.494 |
DBP (mmHg) | 78.6 ± 18.1 | 86.3 ± 14.9 | 81.1 ± 13.5 | 0.038 |
Haemoglobin | 10.3 ± 3.0 | 11.0 ± 3.2 | 9.6 ± 2.7 | 0.071 |
| Â | Median [IQR] | Median [IQR] | Median [IQR] | Â |
Sodium | 138.0 [136.0-141.0] | 138.0 [136.0-142.0] | 138.5 [137.0-141.0] | 0.962 |
Potassium | 4.4 [4.0-4.9] | 4.7 [4.1–5.3] | 4.2 [3.9–4.7] | 0.026 |
Urea | 5.7 [3.8–15.2] | 8.0 [4.3–20.3] | 4.3 [3.0-8.4] | 0.002 |
Creatinine | 167.0 [93.7–354.0] | 180.0 [117.6–364.0] | 129.0 [66.5–244.0] | 0.067 |
eGFR | 45.0 [17.0–96.0] | 38.5 [14.6–71.5] | 51.0 [23.0-114.5] | 0.287 |
MCV | 81.1 [74.4–86.4] | 78.7 [74.1–86.2] | 81.8 [74.4–86.4] | 0.702 |
MCH | 27.7 [25.5–29.5] | 27.7 [25.5–29.7] | 27.8 [24.3–29.3] | 0.409 |
White Blood Count | 5.1 [4.4–6.5] | 5.5 [4.6–6.6] | 4.9 [4.4–6.5] | 0.323 |
Triglycerides | 1.1 [0.8–1.4] | 1.0 [0.7–1.4] | 1.1 [0.9–1.4] | 0.650 |
LDL-c | 3.0 [2.3–4.2] | 2.9 [2.3-4.0] | 3.0 [2.3–4.2] | 0.762 |
HDL-c | 1.3 [1.2–1.8] | 1.2 [0.9–1.3] | 1.7 [1.3–1.9] | 0.001 |
VLDL-c | 0.5 [0.4–0.6] | 0.5 [0.3–0.6] | 0.5 [0.4–0.6] | 0.879 |
Cholesterol | 5.0 [4.1-5.0] | 4.4 [4.0–6.0] | 5.4 [4.1–6.1] | 0.524 |
| Â | Â N (%) | N (%) | N (%) | Â |
Urine Protein | ||||
 Positive | 33/50 (66.0) | 15/22 (68.2) | 18/28 (64.3) | 0.773 |
 Negative | 17/50 (34.0) | 7/22 (31.8) | 10/28 (35.7) | |
Urine Blood | ||||
 Positive | 17/50 (34.0) | 8/22 (36.4) | 9/28 (32.1) | 0.875 |
 Negative | 33/50 (66.0) | 14/22 (63.6) | 19/28 (67.9) | |